# FDA recall D-1290-2020

> **Lupin Pharmaceuticals Inc.** · Class II · drug recall initiated 2020-05-28.

## Product

Lisinopril Tablets, USP, 5 mg, Rx Only, 1000-count bottle, Manufactured for: Lupin Pharmaceuticals Inc., Baltimore, MD 21202, Manufactured by: Lupin Limited, Nagpur - 441 108, India, NDC 68180-513-03.

## Reason for recall

Product Mix Up: Lisinopril 10 mg tablets were found in Lisinopril 5 mg 1000-count bottle.

## Distribution

Nationwide within the US.

## Key facts

- **Recall number:** D-1290-2020
- **Recalling firm:** Lupin Pharmaceuticals Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-05-28
- **Report date:** 2020-06-17
- **Termination date:** 2021-05-04

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Baltimore, MD, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1290-2020

## Citation

> AI Analytics. FDA recall D-1290-2020. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-1290-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*